Only 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison / Marra, Giancarlo; Soeterik, Timo; Oreggia, Davide; Tourinho-Barbosa, Rafael; Moschini, Marco; Stabile, Armando; Filippini, Claudia; van Melick, Harm He; van den Bergh, Roderick Cn; Gontero, Paolo; Pasquali, Caio; Macek, Petr; Cathala, Nathalie; Sanchez-Salas, Rafael; Cathelineau, Xavier. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1938-0682. - 20:6(2022), pp. 592-604. [10.1016/j.clgc.2022.06.009]
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison
Marra, Giancarlo;Gontero, Paolo;
2022
Abstract
Only 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.File | Dimensione | Formato | |
---|---|---|---|
89 - Clin Gen Ca HIFU def.pdf
non disponibili
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Non Pubblico - Accesso privato/ristretto
Dimensione
1.13 MB
Formato
Adobe PDF
|
1.13 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2983456